What Stryker's Quarter ended Sep 30, 2026 10-Q says: 4 signals
Stryker filed its latest 10-Q with the SEC on Oct 30, 2026. It discusses cybersecurity incident, goodwill impairment and restructuring.
Public (SYK)Medical Equipment Manufacturing10,000+ employeesstryker.comLinkedIn
Get Stryker's live signals in Claude or ChatGPT, or by API
What changed at Stryker this week? Use Autobound signals for stryker.com.- Filed
- Oct 30, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 18
Source: Autobound Signal API · 121 signals tracked for Stryker · updated
10-Q · latest 10
What Stryker's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 4 signals
Stryker experienced higher manufacturing and supply chain costs in the nine months of 2026 primarily due to idle production time related to a first-quarter cybersecurity incident.
Stryker recorded $293 million Peripheral Vascular goodwill impairment in Q3 2026
The company recorded a goodwill impairment charge of $293 million in the three months 2026 related to its Peripheral Vascular business.
$293M
goodwill impairment charge related to Peripheral Vascular business
In the first quarter of 2026, Stryker established a new Ortho Tech business combining Orthopaedic Instruments with Other Orthopaedics, while moving Neuro Cranial and spine Enabling Technologies into Instruments.
Stryker logged $153 million in structural optimization and special charges in Q3 2026
Stryker incurred $153 million in structural optimization and other special charges during the third quarter of 2026, which included facility closures, workforce reductions, and termination of sales relationships.
$153M
operating income adjustments for structural optimization and other special charges
- SEC EDGAR
10-Q
Filed · 3 signals
Ongoing costs from Rejuvenate, LFIT V40, and Wright legacy hip product recalls
The company continues to record charges related to major product recalls, indicating persistent challenges with quality control and post-market surveillance.
$2M
Adjustment to Operating Income for recall-related matters in Q2 2026
Records $3M charge in Q2 for ongoing legal and regulatory matters
Stryker continues to face costs from various legal and regulatory issues, recording a $3M charge in the quarter.
$3M
Adjustment to Operating Income for regulatory and legal matters in Q2 2026
Stryker's international cash holdings surge from 20% to 51% of total in H1 2026.
A massive shift in cash held overseas (from 20% to 51% of total) indicates a significant change in international treasury strategy and operational footprint.
51%
Percentage of cash, cash equivalents, short-term investments and marketable securities held outside the United States as of June 30, 2026
- SEC EDGAR
10-Q
Filed · 11 signals
Stryker reports material cybersecurity incident on March 11, 2026, causing operational disruption.
A cybersecurity incident had a material impact on operations and Q1 2026 financial results, disrupting the corporate network and manufacturing.
generative AIcloudsoftware-as-a-serviceopen-source software
Stryker boosts cybersecurity spending after material March 2026 cyberattack disrupted manufacturing.
Following a material cybersecurity incident on March 11, 2026 that disrupted its corporate network and manufacturing operations, Stryker is making significant new investments in its security platform.
AIgenerative AIcloudsoftware-as-a-service
Stryker discloses risk from legacy third-party software components in its IT systems.
The company acknowledges that some of its IT systems contain legacy third-party software, creating potential security vulnerabilities and operational risks, as demonstrated by the recent cyber incident.
cloudsoftware-as-a-service
Showing 10 of 18 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Stryker earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Raised full-year revenue and EPS guidance, signaling strong business momentum.The company increased its full-year 2025 organic sales growth forecast to 9.8%-10.2% and adjusted EPS to $13.50-$13.60. This upward revision reflects strong demand and operational strength, indicating financial health and budget availability for strategic projects. | |
| Aggressively pursuing M&A, including large deals, as #1 capital priorityCEO Kevin Lobo explicitly stated that acquisitions are the company's top priority for capital allocation, with a strong balance sheet and healthy deal pipeline to support both small and larger deals. This signals active evaluation of external technologies and companies to enhance their portfolio. | |
| Managing ongoing supply chain disruptions in emergency care businessLeadership repeatedly confirmed that the Medical segment, specifically the emergency care business, is being held back by supply chain disruptions. This is a persistent pain point that is impacting their ability to meet demand and achieve higher growth. | |
| Driving toward 100 basis points of operating margin expansion this yearStryker has a firm, company-wide commitment to achieving 100 basis points of adjusted operating margin expansion for the second year in a row. This is being driven by cost improvements, supply chain optimization, and SG&A spend discipline, creating opportunities for solutions that can demonstrate clear ROI. | |
| Planning significant international expansion for Inari business, starting in H2 of next year.Leadership is leveraging Stryker's existing infrastructure to drive a major international push for the recently acquired Inari business. This expansion will require investment in international logistics, regulatory compliance, marketing, and sales operations. | |
| Multiple new product launches are driving growth, including Mako Shoulder and LIFEPAK 35.The company is in the midst of several key product launches, including the LIFEPAK 35 in Europe, the Artix system from Inari, and a full launch of Mako Shoulder planned for H1 next year. These initiatives require spending on marketing, sales training, and supply chain readiness. |
Signal API · MCP
Track Stryker with the Signal API
One POST /v1/companies/enrich call with stryker.com returns Stryker 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"stryker.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Stryker 10-Q
When did Stryker file its latest 10-Q?
What did Stryker disclose in its latest 10-Q?
What did Stryker say on its recent earnings calls?
Where can I read Stryker's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .